NGM Bio Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
NGM Biopharmaceuticals (NGM) IPO Opens Lower
April 4, 2019 1:11 PM EDTToday's IPO for NGM Biopharmaceuticals (NASDAQ: NGM) opened for trading at $15 after pricing 6,666,667 shares of common stock at a price to the public of $16.00 per share.
In addition, NGM has granted the underwriters a 30-day option to purchase up to 1,000,000 additional shares... More



